Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Blood Draw

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT00542776Completed

Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine

Showing all 1 trials

Research Network

Common Treatments

  • Blood Draw1

Active Sponsors

  • Boston Children's Hospital1
  • Thrasher Research Fund1

Top Investigators

Related Conditions

  • Seroprotective Titers1
  • Immunosuppressed Or Nonimmunosuppressed1
  • Inflammatory Bowel Disease Ibd1
  • Influenza Vaccine1

Activity Timeline